Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability

J Med Chem. 2003 Jun 5;46(12):2404-12. doi: 10.1021/jm0210717.

Abstract

Novel benzoylalanine-derived ketoamides were prepared and evaluated for calpain I inhibition. Derivatives carrying vinylbenzyl amino residues in the P(2)-P(3) region inhibited calpain in nanomolar concentrations and thus represent a novel class of nonpeptidic calpain inhibitors. Selected examples exhibited an improved pharmacokinetic profile including improved water-solubility and metabolic stability. In particular, these calpain inhibitors showed oral bioavailability in rats as demonstrated by N-(1-benzyl-2-carbamoyl-2-oxoethyl)-2-[E-2-(4-diethylaminomethylphenyl)ethen-1-yl]benzamide (5d). The closely related derivative N-(1-carbamoyl-1-oxohex-1-yl)-2-[E-2-(4-dimethylaminomethylphenyl)-ethen-1-yl]benzamide (5b) was evaluated for neuroprotective efficacy after experimental traumatic brain injury in a fluid percussion model in rats. When administered after injury, 5b reduced the number of damaged neurons by 41%, and this result would be in line with the suggested neuroprotective efficacy of calpain inhibition.

MeSH terms

  • Administration, Oral
  • Alanine / analogs & derivatives*
  • Alanine / chemical synthesis*
  • Alanine / pharmacokinetics
  • Alanine / pharmacology
  • Animals
  • Benzene Derivatives / chemical synthesis*
  • Benzene Derivatives / pharmacokinetics
  • Benzene Derivatives / pharmacology
  • Biological Availability
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Brain Injuries / drug therapy
  • Brain Injuries / pathology
  • Calpain / antagonists & inhibitors*
  • Cell Survival / drug effects
  • Cysteine Proteinase Inhibitors / chemical synthesis*
  • Cysteine Proteinase Inhibitors / pharmacokinetics
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / pathology
  • Humans
  • In Vitro Techniques
  • Male
  • Neuroprotective Agents / chemical synthesis*
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / pharmacology
  • Proto-Oncogene Proteins pp60(c-src) / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Solubility
  • Stereoisomerism
  • Structure-Activity Relationship
  • Vinyl Compounds / chemical synthesis*
  • Vinyl Compounds / pharmacokinetics
  • Vinyl Compounds / pharmacology
  • Water

Substances

  • Benzene Derivatives
  • Cysteine Proteinase Inhibitors
  • Neuroprotective Agents
  • Vinyl Compounds
  • Water
  • Proto-Oncogene Proteins pp60(c-src)
  • Calpain
  • Alanine